Umbilical cord blood has long been recognized as a valuable source of life-saving stem cells. Since the first cord blood transplant was carried out in 1988 for a patient with Fanconi anaemia, it’s estimated that more than 40,000 cord blood transplants have been...
Last month researchers at The Parent’s Guide to Cord Blood Foundation compiled a report about how perinatal stem cells were being employed in clinical trials from 2019 through to the end of 2023. [1] Perinatal stem cells are those which are collected in and around the...
A new therapy, recently granted a UK Innovation Passport Designation, could help to improve treatment outcomes for Krabbe disease patients post-stem cell transplant. What is Krabbe disease? Krabbe disease is a rare genetic disorder affecting around 1 in every...
Advancements in stem cell research are transforming how we approach some of the most critical health conditions. One particularly exciting area is the use of umbilical cord stem cells in treating acute liver failure (ALF). ALF is a life-threatening condition with...
A new clinical trial investigating the use of umbilical cord stem cells to treat chronic heart failure is currently underway. The Phase II trial, which is the first of its kind in the U.S., is being carried out by researchers at the University of Louisville. It’s also...
Last week it was announced that a new gene editing stem cell therapy for beta thalassemia would start to be made available on the NHS. The therapy, called Casgevy, is developed by Vertex Pharmaceuticals and CRISPR Therapeutics and received approval from the UK...
